HUMAN PAPILLOMA VIRUS. NEW OPPORTUNITIES FOR VACCINATION
https://doi.org/10.15690/vsp.v13i6.1200
Abstract
One of the most important problems in the modern world is the papilloma virus infection. As is known, this is the most widely spread sexually-transmitted infection. The human papilloma virus is responsible for the occurrence of such a terrible disease as cervical cancer, which ranks third after breast cancer and cancer of the body in the structure of oncological morbidity organs of the reproductive system and mammary glands in women. The other manifestations of the papilloma virus infection are pointed condyloma genital warts, which occur frequently both in men and in women. The only reliable method of the prevention of the papilloma virus infection is immunization. The authors present new data regarding the use of bivalent vaccine, including a new scheme of immunization for girls from nine to fourteen years old. Foreign investigations showed that the double scheme of introduction of the vaccine in young girls is as effective as a triple scheme of introduction in the category of women over 15 years of age.
About the Authors
A. G. Gaivoronskaya
Scientific Centre of Children's Health, Moscow
Russian Federation
Russian Federation
M. V. Fedoseenko
Scientific Centre of Children's Health, Moscow;
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
D. A. Novikova
Scientific Centre of Children's Health, Moscow
Russian Federation
Russian Federation
N. E. Tkachenko
Scientific Centre of Children's Health, Moscow
Russian Federation
Russian Federation
T. A. Grechukha
Scientific Centre of Children's Health, Moscow
Russian Federation
Russian Federation
F. Ch. Shakhtakhtinskaya
Scientific Centre of Children's Health, Moscow
Russian Federation
Russian Federation
M. I. Broeva
Scientific Centre of Children's Health, Moscow;
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
L. S. Namazova-Baranova
Scientific Centre of Children's Health, Moscow
Sechenov First Moscow State Medical University;
N.I. Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
References
1. Галицкая М. Г., Намазова Л. С., Федосеенко М. В., Гайворон ская А. Г., Алексина С. Г. Педиатрическая фармакология. 2008; 4: 20–24.
2. Goss P. E., Strasser-Weippl K., Lee-Bychkovsky B. L., Fan L., Li J., Chavarri-Guerra Y., Liedke P. E. R., Pramesh C. S., Badovinac Crnjevic T., Sheikine Y., Chen Z., Qiao Y., Shao Z., Wu Y.-L., Fan D., Chow L. W. C., Wang J., Zhang Q., Yu S., Shen G., He J., Purushotham A., Sullivan R., Badwe R., Banavali S. D., Nair R., Kumar L., Parikh P., Subramanian S., Chaturvedi P., Iyer S., Shastri S. S., Digumarti R., Soto-Perez-de-Celis E., Adilbay D., Semiglazov V., Orlov S., Kaidarova D., Tsimafeyeu I., Tatishchev S., Danishevskiy K. D., Hurlbert M., Vail C., Louis J.St., Chan A. Lancet Oncol. 2014; 15: 489–538.
3. Ferlay J., Soerjomataram I., Ervik M. IARC Cancer Base. 2010; 10: 25–29.
4. Чисов В. И., Старинский В. В., Петрова Г. В. М.: ФГУ МНИОИ им. П. А. Герцена МЗ соцразвития РФ. 2010. 260 с.
5. Сухих Г. Т., Прилепская В. Н. М.: МЕДпресс-информ. 2012; 25–26, 176–185.
6. Burd E. M. Clin. Microbiol. Rev. 2003; 16: 1–17.
7. Гайворонская А. Г., Галицкая М. Г. Педиатрическая фармакология. 2008; 6: 6–7.
8. Bosch F. X., Lorincz A., Munoz N., Meijer C. J., Shah K. V. J. Clin. Pathol. 2002; 55: 244–265.
9. Bosch F.X., de Sanjose S. Vaccine. 2008; 26: 1–16.
10. Brown D. R., Schroeder J. M., Bryan J. T., Stoler M. H., Fife K. H. J. Clin. Microbiol. 1999; 37: 3316–3322.
11. Koutsky L. Am. J. Med. 1997; 102: 3–8.
12. Strauss S., Sastry P., Sonnex C., Edwards S., Gray J. Sex Transm Infect. 2002; 78: 135–138.
13. GLOBOCAN 2010/WHO/ICO Information Centre on HPV and Cervical Cancer. Summary Report. WHO. 2010. URL: http://screening.iarc.fr/doc/Human%20Papillomavirus%20and%20Related%20Cancers.pdf
14. Castle P. E., Schiffman M., Herrero R., Hildesheim A., Rodriguez A. C., Bratti M. C. J. Infect. Dis. 2005; 191: 1808–1816.
15. Parkin D. M., Bray F. Vaccine. 2006; 24 (Suppl. 3): 11.
16. Anhang R., Goodman A., Goldie S. J. CA: A Cancer J. Clin. 2004; 54: 248–259.
17. Moscicki A. B., Schiffman M., Burchell A. Vaccine. 2012; 30 (Suppl. 5): 24–33.
18. Stanley M. Vaccine. 2006; 24 (Suppl. 1): 16–22.
19. Steben M., Jeronimo J., Wittet S. Vaccine. 2012; 30 (Suppl. 5): 183–191.
20. World Health Organization. WHO. 2006. 272 p. URL: http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codcch=675
21. Государственный реестр лекарственных средств. Доступно на: http://www.grls.rosminzdrav.ru/Grls_View.aspx?idReg=8169&isOld=1&t= (accessed December 2014).
22. David M. P., Van Herck K., Hardt K., Tibaldi F., Dubin G., Descamps D. Gynecol. Oncol. 2009; 115: 1–6.
23. Cuzick J., Castanon A., Sasieni P. Brit. J. Cancer. 2010; 102 (5): 933–939.
24. Poljak M. Clin. Microbiol. Infect. 2012; 18 (Suppl. 5): 64–69.
25. ГСК данные отчетов по безопасности применения вакцины Церварикс. Данные по запросу.
26. Descamps D., Hardt K., Spiessens B. Hum. Vaccin. 2009; 5: 332–340.
27. Cuschieri K., Brewster D. H., Williams A. R., Millan D., Murray G., Nicoll S., Imrie J., Hardie A., Graham C., Cubie H. A. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. Brit. J. Cancer. 2010; 102: 930–932.
28. Lehtinen M., Paavonen J., Wheeler C. M. Lancet Oncol. 2012; 13: 89–99.
29. Paavonen J., Naud P., Salmerуn J., Wheeler C. M., Chow S. N., Apter D. Lancet. 2009; 374: 301–314.
30. Pedersen C., Petaja T., Strauss G. J. Adolesc. Health. 2007; 40 (6): 564–571.
31. Petaja T., Pedersen C., Poder A., Strauss G., Catteau G., Thomas F., Lehtinen M., Descamps D. Int. J. Cancer. 2011; 129 (9): 2147–2157.
32. Romanowski B., Schwarz T. F., Ferguson L. M., Tino F., Peters K., Dionne M., Schulze K., Ramjattan B., Hillemanns P., Catteau G., Dobbelaere K., Schuind A., Descamps D. Hum. Vaccin. 2011; 7 (12): 1374–1386.
33. Lazcano-Ponce E., Stanley M., Munoz N. Vaccine. 2014; 32 (6): 725–732.
34. WHO Position Paper. WER. 2009; 84: 118–131.
Review
For citations:
Gaivoronskaya A.G., Fedoseenko M.V., Novikova D.A., Tkachenko N.E., Grechukha T.A., Shakhtakhtinskaya F.Ch., Broeva M.I., Namazova-Baranova L.S. HUMAN PAPILLOMA VIRUS. NEW OPPORTUNITIES FOR VACCINATION. Current Pediatrics. 2014;13(6):40-45. (In Russ.) https://doi.org/10.15690/vsp.v13i6.1200
Views:
1587
Email this article 
